Betaseron 0.3 MG kits
Ended Awarded
- Contract number
- SPE2DX25F6UAG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $82,716
Award facts
- Contract value 100% obligated
- $82,716.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits with a ceiling value of $82,716.10 under a firm fixed-price contract type. The award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical vendor, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This award of Betaseron—an immunomodulatory agent used in treating multiple sclerosis—reflects the company's continued role in fulfilling the Department of Defense's pharmaceutical procurement needs through open competition.
Quick answers
Who was awarded contract SPE2DX25F6UAG?
SPE2DX25F6UAG was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2DX25F6UAG worth?
The government has obligated $82,716 on SPE2DX25F6UAG.
Is contract SPE2DX25F6UAG an order under another contract?
Yes. SPE2DX25F6UAG is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6UAG competed?
The extent of competition for SPE2DX25F6UAG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award